Nuvation Bio NUVB Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License | $64.72M+147% | $26.16M+385% | $5.4M+50.1% | $3.6M+16.6% | $3.08M-46.0% | |
| Product Revenue | $18.5M+17.8% | $15.7M+104% | $7.7M+756% | $900K+12.5% | $800K— | |
| Research And Development Service Revenue | $700K— | —— | $1.9M-13.6% | $2.2M+15.8% | $1.9M+103% | |
| Royalty Revenue | $1.4M+367% | $300K0.0% | $300K+50.0% | $200K0.0% | $200K— | |
| Revenue by Geography | ||||||
| CN | $5.19M+434% | $972K-55.5% | $2.18M-34.9% | $3.35M+15.6% | $2.9M-27.2% | |
| JP | $652K-97.4% | $25.19M+684% | $3.21M+1,233% | $241K+31.7% | $183K-89.4% | |
| US | $77.39M+393% | $15.7M+103% | $7.72M+524% | $1.24M— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Nuvation Bio break its business down?
- Nuvation Bio (NUVB) reports revenue by product across 4 parts — License, Product Revenue, Research And Development Service Revenue and Royalty Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Nuvation Bio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nuvation Bio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
